Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2021)

Cogent Biosciences (COGT) has 3 years of Amortizatization of Intangibles data on record, last reported at -$1.4 million in Q4 2021.

  • For Q4 2021, Amortizatization of Intangibles changed N/A year-over-year to -$1.4 million; the TTM value through Dec 2021 reached -$902000.0, changed N/A, while the annual FY2025 figure was $2.0 million, 6.21% up from the prior year.
  • Amortizatization of Intangibles reached -$1.4 million in Q4 2021 per COGT's latest filing, down from $466000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $466000.0 in Q3 2021 and bottomed at -$1.4 million in Q4 2021.
  • Average Amortizatization of Intangibles over 3 years is -$66777.8, with a median of $43000.0 recorded in 2018.
  • The widest YoY moves for Amortizatization of Intangibles: up 1325.0% in 2019, down 102.3% in 2019.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $87000.0 in 2018, then crashed by 102.3% to -$2000.0 in 2019, then crashed by 68200.0% to -$1.4 million in 2021.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$1.4 million in Q4 2021, $466000.0 in Q3 2021, and -$2000.0 in Q4 2019.